Australian Prescriber
| 短名 | Aust. Prescr. |
| Journal Impact | 3.42 |
| 国际分区 | PHARMACOLOGY & PHARMACY(Q2) |
| ISSN | 0312-8008, 1839-3942 |
| h-index | 40 |
AUSTRALIAN PRESCRIBER 是澳大利亚的免费、国家、独立的药物和治疗杂志。它每两个月在线出版一次。我们的目的是帮助卫生专业人员在开药时做出明智的选择，包括是否开药。要做到这一点我们提供独立、可靠和可访问的信息。除了发布简短的教学评论外，我们还促进关于复杂、有争议或不确定的治疗领域的辩论。我们是 NPS MEDICINEWISE 的一部分，这是一个独立的非营利组织，为健康提供药物信息和资源NPS MEDICINEWISE 由澳大利亚政府卫生部资助。
期刊主页| 涉及主题 | 医学生物药理学内科学心理学精神科遗传学化学重症监护医学 |
| 出版信息 | 出版商: Therapeutic Guidelines Ltd，出版周期: Bimonthly，期刊类型: journal |
| 基本数据 | 创刊年份: 1995，原创研究文献占比: 100.00%，自引率:2.90%， Gold OA占比: 100.00% |
| 平均审稿周期 | 网友分享经验：>12周，或约稿 |
| 平均录用比例 | 网友分享经验：容易 |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Pharmacological management of polycystic ovary syndrome
2024-8-19
Diagnostic test: Utility of common investigations for suspected inflammatory arthritis in adults
2024-8-19
Editorial: Achieving safe medication management during transitions of care from hospital: time for a stewardship approach
2024-8-19
Medicinal Mishap: Sum of the parts: a cascade of adverse effects
2024-8-19
New Drug: Rimegepant for migraine
2024-8-19
Letter to the Editor: Mineralocorticoid receptor antagonists in adults with resistant hypertension and obstructive sleep apnoea
2024-8-19
New Drug: Difelikefalin for pruritus associated with chronic kidney disease
2024-8-19
Letter to the Editor: QUM revisited
2024-8-19
Management of occupational exposure to blood and body fluids in primary care
2024-8-19
Deprescribing antihypertensive drugs in frail older adults
2024-6-17
Editorial: Quality use of medicines: who owns it now?
2024-6-17
Latest News: Medicines Repurposing Program – supporting new uses for existing medicines
2024-6-17
Letter to the Editor: Additional preconception considerations for patients with diabetes
2024-6-17
New Drug: Nirsevimab for prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants
2024-6-17
Letter to the Editor: Lipid-lowering therapy in patients with a ‘normal’ LDL-C
2024-6-17
New and emerging drug therapies for Alzheimer disease
2024-6-17
New Drug: Inclisiran for hypercholesterolaemia
2024-6-17
Medicinal Mishap: Thiopurines and risk of lymphoproliferative disorders
2024-6-17
New Drug: Recombinant respiratory syncytial virus (RSV) vaccines for older adults, and pregnant women to prevent disease in their infant
2024-6-17
Controversies in the management of community-acquired pneumonia in adults
2024-6-17
New Drug: Relugolix+estradiol+norethisterone for symptomatic uterine fibroids
2024-4-22
New Drug: Andusomeran and raxtozinameran for prevention of COVID-19 disease
2024-4-22
Biologic therapies for severe asthma with persistent type 2 inflammation
2024-4-22
Diagnosis and management of obstructive sleep apnoea in adults
2024-4-22
Letter to the Editor: Digital health: dashboards, dashboards everywhere
2024-4-22
Letter to the Editor: Evidence-based management of menopause
2024-4-22
Partnered pharmacist medication charting and prescribing in Australian hospitals
2024-4-22
New Drug: Faricimab for neovascular age-related macular degeneration and diabetic macular oedema
2024-4-22
Assessing, communicating and managing cardiovascular disease risk: a practical summary of the 2023 guideline
2024-4-22
Managing hypercholesterolaemia
2024-2-19
Medicinal Mishap: Severe liver injury following use of RAD-140, a selective androgen receptor modulator, for body building
2024-2-19
Managing pre-existing diabetes prior to and during pregnancy
2024-2-19
Latest News: Morphine oral liquid availability
2024-2-19
Therapeutic inertia
2024-2-19
New Drug: Andexanet alfa for reversal of direct factor Xa inhibitor anticoagulation
2024-2-19
Latest News: TGA Medicines Safety Update and Australian Prescriber—back to the future (take 2)
2024-2-19
Diagnosis and management of eosinophilic oesophagitis
2024-2-19
Gabapentinoids: a therapeutic review
2023-12-12
New Drug: Pneumococcal 15-valent and 20-valent conjugate vaccines for prevention of pneumococcal disease
2023-12-11
Ongoing challenges of off-label prescribing
2023-12-11
Latest News: Valediction: John Dowden
2023-12-11
Top 10 drugs 2022–23
2023-12-11
Latest News: Herpes zoster (shingles) vaccination update
2023-12-11
New Drug: Tirzepatide for type 2 diabetes
2023-12-11
Editorial: National Medicines Policy 2.0—what’s changed and what’s next?
2023-12-11
Top 10 drugs 2021–22
2023-12-11
New Drug: Vericiguat for chronic heart failure
2023-12-11
Physical health monitoring for people with schizophrenia
2023-12-11
Editorial: Digital health and prescribing: declare the past, diagnose the present, foretell the future
2023-10-24
New Drug: Finerenone for chronic kidney disease associated with type 2 diabetes with albuminuria
2023-10-24
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远